Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Gait disturbance? 982 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 982 reports of Gait disturbance have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 1.5% of all adverse event reports for AMLODIPINE.

982
Reports of Gait disturbance with AMLODIPINE
1.5%
of all AMLODIPINE reports
85
Deaths
522
Hospitalizations

How Dangerous Is Gait disturbance From AMLODIPINE?

Of the 982 reports, 85 (8.7%) resulted in death, 522 (53.2%) required hospitalization, and 60 (6.1%) were considered life-threatening.

Is Gait disturbance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 982 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Gait disturbance?

DALFAMPRIDINE (8,780) ADALIMUMAB (8,714) ETANERCEPT (6,505) METHOTREXATE (5,141) TOFACITINIB (3,878) PREGABALIN (3,590) DIMETHYL (3,434) SECUKINUMAB (3,222) ABATACEPT (3,110) LEFLUNOMIDE (3,041)

Which AMLODIPINE Alternatives Have Lower Gait disturbance Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Gait disturbance Reports All Drugs Causing Gait disturbance AMLODIPINE Demographics